ApprovalTrail

Approval · Notice of Compliance 12212 · 2011

INDAPAMIDE: Notice of Compliance 12212

Issued March 24, 2011

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
12212
Date
March 24, 2011
Company
Sanis Health Inc.Brampton, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
New manufacturer and product name
Therapeutic class
Diuretic / Antihypertensive agent

Products in this notice

BrandDINStatus today
INDAPAMIDE02365324Cancelled Pre Market

Medicinal ingredients